These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28204651)

  • 1. Yeasts from Scarlet ibises (Eudocimus ruber): A focus on monitoring the antifungal susceptibility of Candida famata and closely related species.
    Brilhante RSN; Silva ALD; Monteiro FOB; Guedes GMM; Sales JA; Oliveira JS; Maia Junior JE; Miranda SA; Sidrim JJC; Alencar LP; Castelo-Branco DSCM; Cordeiro RA; Pereira Neto WA; Rocha MFG
    Med Mycol; 2017 Oct; 55(7):725-732. PubMed ID: 28204651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health.
    Brilhante RSN; de Alencar LP; Cordeiro RA; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Lima DT; Paiva MAN; Monteiro AJ; Alves ND; Franco de Oliveira M; Sidrim JJC; Rocha MFG; Bandeira TJPG; Rodrigues TJS
    J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
    Subramanya SH; Sharan NK; Baral BP; Hamal D; Nayak N; Prakash PY; Sathian B; Bairy I; Gokhale S
    BMC Microbiol; 2017 May; 17(1):113. PubMed ID: 28506251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina.
    Taverna CG; Córdoba S; Vivot M; Szusz W; Vivot W; Bosco-Borgeat ME; Davel G
    Med Mycol; 2019 Apr; 57(3):314-323. PubMed ID: 29955881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Fluconazole-Resistant Candida Species in Tortoises and Sea Turtles.
    Brilhante RS; Rodrigues PH; de Alencar LP; Riello GB; Ribeiro JF; de Oliveira JS; Castelo-Branco Dde S; Bandeira Tde J; Monteiro AJ; Rocha MF; Cordeiro Rde A; Moreira JL; Sidrim JJ
    Mycopathologia; 2015 Dec; 180(5-6):421-6. PubMed ID: 26363919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal susceptibility of emerging yeast pathogens].
    García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
    Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil.
    Costa AK; Sidrim JJ; Cordeiro RA; Brilhante RS; Monteiro AJ; Rocha MF
    Mycopathologia; 2010 Mar; 169(3):207-13. PubMed ID: 19847668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals.
    Eddouzi J; Lohberger A; Vogne C; Manai M; Sanglard D
    Med Mycol; 2013 Oct; 51(7):737-46. PubMed ID: 23768242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fruits as the vehicle of drug resistant pathogenic yeasts.
    Lo HJ; Tsai SH; Chu WL; Chen YZ; Zhou ZL; Chen HF; Lee CF; Yang YL
    J Infect; 2017 Sep; 75(3):254-262. PubMed ID: 28648496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.